Publix postpones Miracle Mile GreenWise opening
VERO BEACH, Fla. Publix Super Markets has placed on hold plans to open a Publix GreenWise organic grocer here, according to reports published Wednesday.
Plans for the Vero Beach store have slowed while the grocer focuses on opening its GreenWise concept in Boca Raton, Kim Jaeger, Publix spokeswoman, told Stuart News Group.
According to the Stuart News report, Publix had announced last September the first GreenWise Market would open on Miracle Mile in Vero Beach during the third quarter of 2008.
Rite Aid kicks off Children’s Miracle Network campaign
CAMP HILL, Pa. Rite Aid plans to kick off its national fundraising campaign for Children’s Miracle Network this Sunday, the retailer announced Thursday, and will continue those fundraising efforts through May 10 through the sale of $1 paper Miracle Balloons to customers.
Last year, Rite Aid associates raised more than $5.3 million for Children’s Miracle Network. Rite Aid has raised more than $31 million since 1994 for 117 pediatric hospitals.
“One of Rite Aid’s core values is that we are a caring neighbor, involved in community activities in meaningful ways,” stated Mary Sammons, Rite Aid chairman, president and chief executive officer. “Rite Aid associates are committed to giving back to the local communities that we serve. Each year, our associates do an outstanding job of coming up with creative ways of getting their communities involved in raising a lot of money for local children who need help.”
In addition to selling $1 paper Miracle Balloons, Rite Aid associates have created their own ideas to raise funds for the charity, including bake sales, carnivals and car washes. Last year, one store manager in Wytheville, Va., held an archery tournament and raised more than $800. Executives at Rite Aid’s headquarters in Camp Hill, Pa., washed employees’ cars and competed in an obstacle course, raising $200,000 for the local children’s hospital.
FDA approves new cancer drug from Cephalon
WASHINGTON The Food and Drug Administration ahs announced its approval of Cephalon’s new cancer drug, Treanda. This recent approval hopes to raise the company’s shares, which have fallen 29 percent since June, published reports claim.
Treanda, indicated for chronic lymphocytic leukemia, was granted priority review by the FDA. The FDA approval of Treanda will mark the first big step in the oncology department for Cephalon, which normally makes its sales on pain relievers and treatments for central-nervous-system disorders. According to reports, the approval of this drug will bring it close to competing with major drug companies.
The approval of Treanda not only is expected to raise the share price of the company, but will also pave the way for Cephalon to introduce more cancer-related drugs into the market. As a result, shares of Cephalon were up $2.79, or 4.7 percent, to $62.14.